相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
M. F. Dohrn et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
Alaa Othman et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
D. Lee Gorden et al.
JOURNAL OF LIPID RESEARCH (2015)
Lowering Plasma 1-Deoxysphingolipids Improves Neuropathy in Diabetic Rats
Alaa Othman et al.
DIABETES (2015)
Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus
Alaa Othman et al.
BMJ OPEN DIABETES RESEARCH & CARE (2015)
PLASMA SPHINGOLIPID PROFILING REVEALS NOVEL DISTINCT BIOMARKERS FOR PREDICTING CARDIOVASCULAR DISEASE AND TYPE 2 DIABETES MELLITUS
A. Othman et al.
ATHEROSCLEROSIS (2014)
Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells
Richard A. Zuellig et al.
DIABETES (2014)
A Ceramide-Centric View of Insulin Resistance
Jose A. Chavez et al.
CELL METABOLISM (2012)
Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease
Jayani Manchanayake et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Circulating sphingolipid biomarkers in models of type 1 diabetes
Todd E. Fox et al.
JOURNAL OF LIPID RESEARCH (2011)
Deoxysphingoid bases as plasma markers in Diabetes mellitus
Mariana Bertea et al.
LIPIDS IN HEALTH AND DISEASE (2010)
The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome
Mathieu Firmann et al.
BMC CARDIOVASCULAR DISORDERS (2008)
Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort
Elisabet Nerpin et al.
DIABETES CARE (2008)
分享论文
